The Intelligence from The Economist cover image

So the Tory goes: Britain’s Conservatives meet

The Intelligence from The Economist

00:00

Underutilized Medications for Alcohol Use Disorder

This chapter explores the limited prescription rates of three FDA-approved medications—disulfiram, naltrexone, and acamprosate—despite their proven efficacy in treating alcohol use disorder. It also discusses the potential of emerging treatments like semaglutide and the influence of societal perceptions on the acceptance of these therapies.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app